Skip to content

Single Versus Dual Antioxidants as an Adjuvant Treatment in Acute Aluminum Phosphide Poisoning

Single Versus Dual Antioxidants as an Adjuvant Treatment in Acute Aluminum Phosphide Poisoning

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
PACTR
Registry ID
PACTR202503804578932
Enrollment
120
Registered
2025-03-11
Start date
2025-09-01
Completion date
Unknown
Last updated
2026-01-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Injury, Occupational Diseases, Poisoning

Interventions

Conventional treatment

Sponsors

Tanta University Hospitals
Lead Sponsor

Eligibility

Sex/Gender
All

Inclusion criteria

Inclusion criteria: ? adult patients (aged 18 years or older) ? symptomatic acute ALP poisoning ? admitted within 12 hours of exposure

Exclusion criteria

Exclusion criteria: ? Patients aged less than 18 years old ? Patients died shortly after admission ? Patients with pre-existing chronic diseases (e.g. cardiovascular disease, renal or hepatic failure, diabetes, and chronic pulmonary disease) ? Patients with combined drug or chemical compound ingestion in addition to ALP ? Patients who received any medical intervention before admission ? Pregnant and lactating women ? Patients with known hypersensitivity to NAC or using it for other diseases ? Patients receiving chemotherapeutic drugs or warfarin treatment

Design outcomes

Primary

MeasureTime frame
In-hospital mortality

Secondary

MeasureTime frame
Duration of mechanical ventilation ;Duration of hospital stay;Troponin I;Incidence of adverse events.;Time to recovery from critical symptoms (e.g., return of normal GCS, resolution of acidosis).;Total antioxidant capacity;Malondialdehyde levels;Hemodynamic stability (blood pressure);arterial blood gases

Countries

Egypt

Contacts

Public ContactMona Ghonem

assistant professor of forensic medicine and clinical toxicology

mona.ghonaim@med.tanta.edu.eg+201064257070

Outcome results

None listed

Source: PACTR (via WHO ICTRP) · Data processed: Feb 4, 2026